Next report date
Report period
Q1 2024
EPS estimate
−0.19USD
Revenue estimate
—
−36.01 MUSD
49.50 M
Om MoonLake Immunotherapeutics
Sektor
Bransch
VD
Jorge Santos da Silva
Webbplats
Huvudkvarter
Zug
Employees (FY)
50
Grundat
2021
FIGI
BBG00XQZQTS9
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
